The interaction between early proneural genes and lateral inhibition determines the number of primary neurons. The mechanism for regulating the size of the proneural domain, however, has not been clarified. We show here that inhibition of the function of XETOR in Xenopus, a homolog of human oncoprotein ETO/MTG8, leads to a neurogenic phenotype of expanded proneural domain without alteration in the density of primary neurons. This result suggests that XETOR is a prerequisite for regulating the size of the proneural domain. We further show that such a regulation is accomplished by establishing a negative feedback loop between XETOR and proneural genes except Xngnr-1, as well as by antagonism between XETOR and lateral inhibition. q
Introduction
Primary neurogenesis is promoted by proneural genes that provide neuroectodermal cells with the potential to adopt a neural fate (reviewed in Lee, 1997) . In Xenopus laevis, the earliest expressed proneural gene is Xngnr-1, which begins to express at stage 10.5 (Nieuwkoop and Faber, 1967) . It defines the three prospective patches of primary neurons in the neural plate . Downstream genes such as Xath3, XNeuroD and Xebf3 are activated at stages 12, 13.5 and 15.5, sequentially, in a unidirectional way Takebayashi et al., 1997; Lee et al., 1995; Perron et al., 1999; Pozzoli et al., 2001) . All these genes can induce ectopic neuron formation in naïve ectoderm when overexpressed. Xash-3 is another proneural gene activated by Xngnr-1. It promotes primary neuron formation, but only within the proneural domain (Zimmerman et al., 1993; Chitnis and Kintner, 1996) . Xngnr-1 also activates a zinc-finger gene XMyT1 at stage 11.5 to stabilize the competent state of neuronal determination (Bellefroid et al., 1996) . The temporal sequence of expression of these genes and the unidirectional way of activation reflect that they regulate successive stages of primary neurogenesis.
Primary neurogenesis is, on the other hand, repressed by neurogenic genes. In Drosophila, the products of neurogenic genes Delta and Notch comprise a cell-cell signaling termed lateral inhibition whereby a cell committed to neural fate forces its neighbors to remain non-neural (reviewed in Artavanis-Tsakonas et al., 1995; Kopan and Turner, 1996; Beatus and Lendahl, 1998) . The proneural proteins enhance the expression of the inhibitory ligand gene Delta (Kunisch et al., 1994) , and, in turn, they are inhibited by signaling via the receptor encoded by Notch in the neighboring cells. By this way, cells expressing proneural genes and hence Delta adopt a neural fate while their neighbors remain non-neural. When in Drosophila these genes are mutated, this will result in a massive over-production of neurons, hence the name 'neurogenic genes'. Homologs of Delta and Notch in Xenopus, X-Delta-1 and X-Notch-1, control the number of primary neurons similar to Drosophila (Chitnis et al., 1995; reviewed in Beatus and Lendahl, 1998) . Blocking lateral inhibition leads to increased density of primary neurons within the neuronal domain. In contrast, when it is activated, primary neuron formation is repressed (Chitnis et al., 1995) , as a result of inhibition of proneural genes including Xngnr-1, Xash-3, and Xath3 Chitnis and Kintner, 1996; Perron et al., 1999; Bellefroid et al., 1996) . Therefore, lateral inhibition is essential for keeping the balance between the number of neuronal precursors and the number of primary neurons.
Blocking of lateral inhibition leads to increased density of Mechanisms of Development 119 (2002) [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] primary neurons without alteration in the size of the proneural domain. This indicates that lateral inhibition regulates primary neurogenesis by limiting only the number of primary neurons. It is interesting to note that early genes for primary neurogenesis define the proneural domains much larger than the area where primary neurons form, as shown by much larger expression domains of Xngnr-1, XMyT1 and Xath3 than those of N-tubulin (Fig. 1) . Furthermore, the early genes often have broader expression domains than those of late expressed ones, i.e. Xngnr-1, XMyT1 and Xath3 are expressed in broader domains than XNeuroD Perron et al., 1999; Bellefroid et al., 1996; Lee et al., 1995; Fig. 1) . These facts suggest that there should be a mechanism to regulate the size of the proneural domain. The proto-oncogene ETO (for Eight-Twenty One, also known as MTG8 or CDR) encodes a protein with potent activity of transcriptional repression. ETO on chromosome 8 in human is often translocated to AML1 on chromosome 21 to make a fusion transcript in acute myeloid leukemias (Feinstein et al., 1995; Melnick et al., 2000; Wang et al., 1998) . The ETO coding sequence has also been revealed to be conservative through Drosophila to human (Feinstein et al., 1995; Kitabayashi et al., 1998) . One attractive feature of these genes is that they are mainly expressed in the nervous system in different species (Feinstein et al., 1995; Wolford and Prochazka, 1998) , suggesting that they should be functionally conservative. But so far no functional analyses have been made for these genes during the development of nervous systems.
In the following, we will show the molecular cloning of XETOR, an ETO-related gene in Xenopus, and its functions during primary neurogenesis. Briefly, we found that expression of XETOR starts from stage 12.5 in a pattern similar to that of primary neuron marker genes. By both gain-of-function and loss-of-function analyses, we found that XETOR is an inhibitory factor to regulate the size of the proneural domain during primary neurogenesis. We propose that lateral inhibition and XETOR comprise a dual inhibitory mechanism to regulate the number of primary neurons and the size of the proneural domain.
Results

Identification of XETOR -a novel Xenopus homolog to ETO/MTG8 oncogene
Using large-scale whole mount in situ hybridization, we identified a partial cDNA with expression in the nervous system from a library constructed with induced endodermlike tissue (Cao et al., 2001 ). The complete coding region was obtained with 5 0 -rapid amplification of cDNA ends (RACE). It encodes a protein of 586 amino acids with an overall homology of 72% to MTG8-like protein MTGR1, 59% to ETO in human, and 29% to Nervy in Drosophila (Fig. 2) . MTG8 (also known as ETO or CDR) is a protooncogene because it composes most of the fusion transcript that is consistently present in acute myeloid leukemias containing the t(8;21) translocation. XETOR in structure like other ETO/MTG8 related proteins has four conserved domains termed nervy homologous regions (NHRs; NHR1, aa101-198; NHR2, aa336-363; NHR3, aa426-474; NHR4, aa497-534; Fig. 2 ), because they share greater than 45% homology in these regions. NHR1 is homologous to TATA-binding protein-associated factors (Erickson et al., 1994; Feinstein et al., 1995) and NHR2 is a helical domain (Kitabayashi et al., 1998) with an oligomerization function (Zhang et al., 2001) . NHR3 also has a helical structure (Hildebrand et al., 2001) , while NHR4 corresponds to two zinc-finger motifs (-C-x-x-C-7x-C-x-x-C-;-C-x-x-x-C-7x-H-x-x-x-C-; Fig. 2 ) (Feinstein et al., 1995; Kitabayashi et al., 1998) . It was therefore named as Xenopus ETO related protein (XETOR), and the nucleotide sequence was submitted to Genbank under accession number AF212198.
Expression pattern of XETOR
XETOR transcripts in the nervous system were first detected within the dorsal ectoderm at stage 12.5 in a pattern of symmetrical stripes on either side of the dorsal midline of posterior neural plate (Fig. 3A) . This pattern grows more prominent with the completion of gastrulation and during neurulation, after the neural plate has narrowed by convergent extension movements (Fig. 3B,D,E) . The pattern of three longitudinal domains anticipates the expression of N-tubulin, which was previously shown to mark primary neurons. These primary neurons are formed in lateral, intermediate and medial stripes that will differentiate into motorneurons, interneurons and sensory neurons (Rohon-Beard cells), respectively, on either side of dorsal midline (Oschwald et al., 1991; Chitnis et al., 1995) . In the anterior neural plate, expression of XETOR was also detected in a lateral group of cells associated with trigeminal ganglia, an extreme anterior group of cells associated with olfactory Fig. 1 . Proneural genes define broader domains than the area where primary neurons occur, and early proneural genes have also broader domains than late ones. Xngnr-1, XMyT1, Xath3, XNeuroD and N-tubulin is expressed at stages 10. 5, 11.5, 12, 13.5 and 12.5, respectively. placode, a central stripe corresponding to the sites of future brain and in the prospective anterior neural crest cells (Fig.  3B-D) . It is noteworthy that there is also an expression domain of XETOR on the ventral side (Fig. 3C ). This domain is reminiscent of the expression of Xaml in ventral blood islands (Tracey et al., 1998) . The ventral expression of XETOR seems to persist only in a very short time window between stages 12 and 14. The expression domain of XETOR should be overlapping with that of N-tubulin as observed via side-by-side comparison (Fig. 3H ). This overlapping expression was confirmed by section through an embryo with double in situ hybridization (Fig. 3I ). In summary, such an expression pattern shows that XETOR is expressed at the location where primary neurogenesis occurs, and is therefore a marker for early embryonic neurogenesis.
From stage 24 onward, XETOR is expressed exclusively in the neural system, including the spinal cord, forebrain, midbrain, hindbrain, eyes, and olfactory placodes (Fig. 3F) . At around stage 32, the expression in spinal cord fades out and is principally restricted to midbrain, hindbrain and the sensory organs in the head area (Fig. 3G ).
Overexpression of XETOR inhibits the formation of primary neurons while the neural plate expands
The function of XETOR during primary neurogenesis was investigated with overexpression experiments. XETOR mRNA was injected together with LacZ serving as lineage tracer in the equatorial region of one blastomere at two-cell stage, while the other served as internal control. When the embryos were grown to neural plate stage (stages 14-16), they were fixed and subjected to whole mount in situ hybridization. First, we observed that expression of N-tubulin, a marker gene for differentiated neurons (Oschwald et al., 1991) , was dramatically downregulated and even totally Fig. 4C ), a sensory neuron marker gene (Tracey et al., 1998; Perron et al., 1999) . The data showed that XETOR inhibits the formation of primary neurons. Then we asked if the inhibition of primary neurons was the consequence of disruption of neural plate. This seemed not to be the case because the expression of a neural plate marker gene Xsox3 (Penzel et al., 1997) expanded in response to XETOR overexpression (49/86 embyros; Fig. 4D ). This primary data indicate the specific inhibition of expression of primary neuron marker genes by XETOR overexpression, and therefore suggest that XETOR should have functions in regulating neuronal differentiation and in neural tissue. The functional analysis on XETOR was focused on primary neurogenesis.
Truncation mutants of XETOR behave similarly to the wild-type protein
All the members of ETO oncoprotein family have four conservative domains (Fig. 2) . It is interesting to study the functions of these domains for XETOR activity. A series of truncation mutants (Fig. 4F) were tested during primary neurogenesis. Unexpectedly, overexpression of all mutants caused inhibition of N-tubulin expression, resulting in a phenotype similar to that caused by XETOR overexpression (data not shown). In all 25 embryos overexpressing p13#trunc1, expression of N-tubulin was inhibited; in 25 out of 29 embryos overexpressing p13#trunc2, N-tubulin expression was repressed; for p13#trunc4 and p13#trunc5 overexpression, N-tubulin expression was repressed in 26/ 26 and 30/36 embryos, respectively. The data demonstrate that the four mutants have an effect on N-tubulin expression indistinguishable from the wild-type protein. Although overexpression of p13#trunc3 inhibits N-tubulin expression also, it is not as efficient as the other mutants and the wildtype protein. In 29 embryos, only 14 showed the phenotype of inhibited N-tubulin expression (Fig. 4E) . Moreover, the inhibition effect in these affected embryos is also not as robust as in embryos overexpressing the wild-type XETOR or other mutants, in which the N-tubulin expression was completely eradicated in most cases. The data suggest that either NHR1 and 2 together or NHR3 and 4 together are sufficient for XETOR function.
XETOR is required for regulating the size of the proneural domain
Overexpression of XETOR or a series of truncation mutants exclusively inhibits primary neuron formation. Therefore, we asked what would happen if the function of endogenous XETOR will be inhibited. Antisense morpholino oligo (7-30 ng) against XETOR (MOXETOR) was injected and the embryos were analyzed with N-tubulin expression. In the injected embryos, the lateral stripe of N-tubulin expression domain expanded but the density of primary neurons looked similar to those in the control side (43/50 embryos, Fig. 5A ). A control morpholino oligo (ctrlMO) was also injected, and no discernible effect was observed (22/26 embryos, Fig. 5B ). Therefore, injection of MOXETOR generated a neurogenic phenotype as the proneural domain expanded. Further injections were made to see if the phenotype by XETOR overexpression could be rescued by MOXETOR, or vice versa. It proved to be the case because when XETOR (2 ng) was coinjected with MOXETOR (30 ng), the expression of N-tubulin was neither inhibited nor increased appreciably (49/55 embryos, Fig.  5C ). These data indicate that MOXETOR is able to abolish specifically the function of XETOR. Inhibition of XETOR function results in an expansion of the proneural domain, the nearly normal salt-and-pepper pattern of primary neurons in the domain seems to be the result of the action of lateral inhibition. We further tested the idea by repressing both XETOR and lateral inhibition. As previously reported, when lateral inhibition alone is blocked by overexpression of a dominant-negative form of X-Delta-1, X-Delta-1 STU , an increased density of neurons in the lateral stripe without significant change of the size of the stripe is largely unchanged (Chitnis et al., 1995; Chitnis and Kintner, 1996 ; Fig. 5D ). However, when MOXETOR and X-Delta-1 STU were coinjected, an increased density of neurons was observed in an enlarged lateral stripe (55/59 embryos; Fig.  5E ). This phenotype is in striking contrast not only to that caused by MOXETOR injection alone (Fig. 5A ) but also by X-Delta-1 STU injection alone (Fig. 5D ). These data suggest that XETOR is necessary for regulation of the size of the proneural domain.
XETOR and lateral inhibition are negatively crossregulated
We have demonstrated that XETOR overexpression generated a phenotype similar to that caused by enhancing lateral inhibition, the primary signaling pathway known so far for repressing neurogenesis. We therefore asked whether the function of XETOR is orchestrated by lateral inhibition. First, we observed that overexpression of XETOR repressed the expression of the ligand gene X-Delta-1 (25/27 embryos; Fig. 6A ). Meanwhile, when lateral inhibition was activated by overexpression of X-Notch-1ICD, the dominant active form of X-Notch-1, expression of XETOR was inhibited (24/24 embryos; Fig. 6B) . XETOR expression was also tested in embryos in which lateral inhibition was blocked. We noted that expression of XETOR also increased significantly (35/35 embryos), when lateral inhibition signaling was blocked (Fig. 6C ). The data demonstrate that XETOR and lateral inhibition signaling antagonize each other. Second, as blocking of lateral inhibition signaling can increase the expression of both XETOR and N-tubulin, we therefore examined whether XETOR still inhibits primary neuron formation when lateral inhibition is blocked. It was proved to be the case because N-tubulin expression was repressed when XETOR was coinjected together with XDelta-1 STU , showing that X-Delta-1 STU does not have rescuing effect on the inhibition by XETOR (14/15 embryos; Fig.  6D ). These primary data suggest that XETOR is not a component of lateral inhibition signaling pathway but functions independently.
To gain further support for the idea, expression of two Notch downstream target genes, ESR1 (Wettstein et al., 1997) and XNAP (Lahaye et al., 2002) , was examined in response to XETOR overexpression. Normally, expression of the two genes is positively regulated by Notch pathway. We observed that, however, no changes occurred in the expression of ESR1 (40/42 embryos) and XNAP (29/29 embryos) in response to XETOR overexpression (Fig.  6E,F) . Moreover, intact expression of ESR1 (28/31 embryos) and XNAP (30/31 embryos) were likewise observed when endogenous XETOR activity was extirpated via MOXETOR injection (Fig. 6G,H ). All the evidence shows that XETOR is not a constituent of the Notch pathway.
Crossregulation between XETOR and the proneural genes
We then asked how the crossregulation takes place between XETOR and the proneural genes. At transcriptional level, overexpression of both Xngnr-1 (32/32 embryos; Fig.  7A ) and Xath3 (25/25 embryos; Fig. 7B ) activated strong ectopic expression of XETOR. Conversely, overexpressed XETOR had no appreciable effect on the expression of Xngnr-1 (43/43 embryos; Fig. 7C ), but downregulated the expression of Xath3 (20/22 embryos; Fig. 7D ). Overexpression of Xash-3 caused an enhancement of XETOR expression within its normal expression domains (36/40 embryos; Fig. 7E ), but no discernible change in Xash-3 expression was observed in response to XETOR overexpression (55/ 59 embryos, Fig. 7F ). We further observed that expression of the zinc-finger protein gene XMyT1 was inhibited by XETOR overexpression (17/19 embryos; Fig. 7G ), while overexpressed XMyT1 did not affect XETOR expression (data not shown). XNeuroD, a gene expressed for terminal differentiation of neurons in later stage, was found to enhance XETOR expression also (37/39 embryos; Fig. 7H ).
Then we tested if XETOR also inhibits the neuron inducing activity of these genes. mRNA of XETOR was coinjected together with mRNA of either of the the proneural genes Xngnr-1, XMyT1, Xash-3, Xath3 and XNeuroD. Ntubulin expression was subsequently analyzed in injected embryos. As previously reported, overexpression of Xngnr-1, Xath3 and XNeuroD activates significantly ectopic neuron formation Lee et al., 1995; Chitnis and Kintner, 1996; Perron et al., 1999; Fig. 7I,K,M) . We observed that overexpressed XETOR did not significantly repress the ectopic N-tubulin expression induced by Xngnr-1 (15/15 embryos; Fig. 7J ). However, it inhibited the ectopic or even the endogenous N-tubulin expression when coinjected with Xath3 (23/23 embryos; Fig. 7L) or Crossregulation between the expression of XETOR and proneural genes. Overexpression of Xngnr-1 (A) or Xath3 (B) induces significant ectopic XETOR expression. In turn, overexpression of XETOR does not affect Xngnr-1 expression (C), but inhibits Xath3 expression (D). XETOR expression is also activated or enhanced by overexpressed Xash-3 (E), or XNeuroD (H). Conversely, overexpression of XETOR inhibits the expression of XMyT1 (G), but not Xash-3 (F). (I-R) Overexpression of XETOR inhibits the function of proneural genes, except Xngnr-1. Overexpressed Xngnr-1 (I), Xath3 (K), or XNeuroD (M) induces strong ectopic neuron formation. Overexpressed XETOR does not inhibit the activity of Xngnr-1 (J), but inhibit the activity of Xath3 (L) and XNeuroD (N). The neuron inducing activity of Xash-3 (O) and XMyT1 (Q) is also inhibited by XETOR (P, R).
XNeuroD (10/10 embryos; Fig. 7N ). Xash-3 consistently induces neuron formation within the proneural domains when lateral inhibition is blocked, as shown previously (Chitnis and Kintner, 1996; Fig. 7O) . Such an activity was also inhibited in response to XETOR overexpression (7/8 embryos; Fig. 7P) . Similarly, the neuron inducing activity of XMyT1 (Bellefroid et al., 1996;  Fig. 7Q ) was repressed by overexpressed XETOR (29/29 embryos; Fig. 7R ).
Discussion
Here in this study, we present for the first time the expression and function of XETOR, an ETO-related gene, during primary neurogenesis in Xenopus laevis. Like other members of ETO oncogene family, XETOR is also expressed primarily in the nervous system. Both gain-and loss-of-function studies showed that XETOR plays a key role in the regulation of the size of the proneural domain.
3.1. XETOR is an inhibitory factor for primary neurogenesis independent of lateral inhibition XETOR encodes a putative protein that shares all characteristics of other members of oncoprotein family ETO/ MTG8: the four conserved NHRs and the two unusual zinc-finger motifs. Another feature shared among these genes examined, including Nervy in Drosophila, is that they all are expressed in the nervous system (Feinstein et al., 1995; Wolford and Prochazka, 1998) . This suggests a conserved function of ETO proteins in nervous system. Expression of XETOR begins at stage 12.5 in a pattern of longitudinal stripes at either side of the dorsal midline, similar to the patterns of other primary neuron marker genes. Expression of XETOR starts at stage 12.5, following that of Xngnr-1, Xash-3, XMyT1, X-Delta-1, Xath3 and preceeding that of XNeuroD, but at the same time when N-tubulin, the marker gene for differentiated neurons, is turned on. This temporal sequence should suggest that XETOR is switched on when neuronal differentiation begins.
We demonstrate that XETOR is an inhibitory factor for primary neurogenesis. First, gain-of-function data show that XETOR inhibits expression of neuron marker genes N-tubulin and Xaml. This loss of primary neuron formation is not a result of a disruption of the neural plate because the neural plate expands rather than narrows in response to XETOR overexpression, as indicated by expanded expression of Xsox3. These data are similar to those for Xiro3, a homeobox-containing gene which also inhibits primary neuron formation and promotes neural tissue in Xenopus (Bellefroid et al., 1998). Second, XETOR inhibits not only the expression of the proneural gene Xath3 and the zinc finger gene XMyT1, but also the neuron inducing activities of Xash-3, Xath3, XNeuroD and XMyT1. Therefore, XETOR should be able to inhibit primary neuron formation via repressing the expression and function of the proneural genes. Third, inhibition of XETOR function in vivo leading to a neurogenic phenotype of expanded the proneural domain also suggests that XETOR is a key negative regulator for primary neurogenesis.
A negative feedback loop is established between XETOR and the proneural genes. The reason is that expression of XETOR is exclusively activated or promoted by the genes examined in the study except the zinc-finger gene XMyT1. In turn, XETOR inhibits the function of these genes, except Xngnr-1. A similar feedback mechanism also exists between proneural genes and lateral inhibition. We therefore tested whether XETOR is a component of this signaling pathway. A few lines of evidence negate the idea, but support that XETOR and lateral inhibition are different working mechanisms. First, expression of X-Delta-1 is repressed in response to overexpressed XETOR, and vice versa, XETOR expression is inhibited by activated lateral inhibition. Moreover, when lateral inhibition is blocked, XETOR expression is promoted. This phenomenon is just contrary to that for Notch targets, which are promoted by activated lateral inhibition pathway while repressed by the blocked pathway. Therefore, lateral inhibition and XETOR is a pair of antagonists. The second is that XETOR still efficiently inhibits Ntubulin expression in the absence of lateral inhibition, as shown by coinjection of XETOR and X-Delta-1 STU . Third, expression of Notch target genes, ESR1 and XNAP, is not affected either with XETOR or without XETOR. It is interesting to note that XETOR does not affect the expression and function of Xngnr-1. However, it inhibits the function of XNeuroD. This situation is just in contrast to that for lateral inhibition because lateral inhibition represses the function of Xngnr-1 but not XNeuroD (Chitnis and Kintner, 1996) . Such a line of evidence suggests again that XETOR should not be mediated by lateral inhibition. Instead it suggests that lateral inhibition regulates early stage while XETOR regulates late stage of primary neurogenesis.
The molecular mechanism of transcriptional repression activity of XETOR
The initial idea for constructing truncation mutants of XETOR was to test whether in loss-of-function assays, any one of them could function antimorphically to the wild-type protein. Unexpectedly, all these truncation mutants exclusively exhibit a repression effect, showing that XETOR is a robust transcription repressor. One principal mechanism for transcriptional repression is the modification of chromatin conformation by histone deacetylases (HDACs; reviewed in Struhl, 1998; Torchia et al., 1998) . It has been shown so far that, except NHR1 and its N-terminal flanking region, all other three conserved NHR domains and flanking sequences of ETO are able to recruit directly the first class HDACs (HDAC1, 2, and 3) (Amann et al., 2001) . Moreover, these regions can also bind to corepressors nuclear receptor corepressor (N-CoR), mSin3A or silencing mediator for retinoid and thyroid-hormone receptors (SMRT) (Amann et al., 2001; Gelmetti et al., 1998; Lutterbach et al., 1998; Wang et al., 1998; Hildebrand et al., 2001 ), which in turn recruit either the first class HDACs or the second class HDACs (HDAC4, 5, and 7) (Kao et al., 2000; Huang et al., 2000; Heinzel et al., 1997) . In addition, ETO itself acts also as a corepressor recruited by promyelocytic leukemia zinc finger protein (PLZF), which mediates transcriptional repression via the action of HDACs (Melnick et al., 2000) . Considering both sequence and structure similarities between ETO and XETOR, it is possible that XETOR mediates transcriptional repression also by recruitment of these HDACs or corepressors in Xenopus. The data on ETO may explain why deletion of one or two NHRs in XETOR does not affect significantly the efficacy of its repression activity.
3.3. A new model for primary neurogenesis: lateral inhibition and XETOR comprise a dual inhibitory mechanism to define the exact number of primary neurons and the size of the proneural domain Functional knockout of XETOR alone results in a neurogenic phenotype of significantly enlarged proneural domain. However, the density of neurons does not vary substantially. These data suggest a role for XETOR in regulating the size of the proneural domain. Double depletion of XETOR and lateral inhibition caused a phenotype of increased density of neurons in enlarged proneural domain. The result suggests that lack of either one will lead to overproduction of primary neurons either in an extra large sized proneural domain or in an excessive density. Hence, lateral inhibition and XETOR must cooperate to define the exact number of primary neurons and the size of the proneural domain.
We propose a two-step model for primary neurogenesis (Fig. 8) . The first step, based on previous studies, the interaction between lateral inhibition and early proneural genes, for instance Xngnr-1 and Xath3, determines the number of primary neurons via cell fate selection. This procedure occurs in a broad proneural domain defined by these early proneural genes. The second step should be, therefore, the regulation of the size of the proneural domain. It is proposed here that XETOR plays such a role because of a few lines of evidence. The most direct evidence is that eradication of XETOR function in vivo results in an enlargement of the proneural domain, as discussed above. Further, each proneural gene activates three things: lateral inhibition, XETOR and the downstream proneural genes. Considering additionally that lateral inhibition and XETOR antagonize each other, it would be reasonable to assume that lateral inhibition and XETOR could exert their functions in exclusive regions in the proneural domain. Due to the inhibitory effect of XETOR on the expression and function of proneural genes, the proneural domain defined by the downstream proneural gene will be more restricted than the domain defined by the upstream gene. In summary, during primary neurogenesis, lateral inhibition and XETOR comprise a dual inhibitory mechanism to define the exact number of primary neurons and the size of the proneural domain, via repressing the expression and function of proneural genes.
The functions of proneural and neurogenic genes are conservative throughout the spectrum of organisms from Drosophila to Xenopus. It has been shown that there also exist XETOR homologs in other organisms, including Nervy in Drosophila. Moreover, the expression of these homologues is restricted to the nervous system also. It is logical to deduce that certain XETOR homologs in other organisms play the same or at least similar role. Hence the dual inhibitory mechanism identified in this study may also be conserved in other organisms.
Experimental procedures
Molecular cloning of XETOR
A lZAP Express phage cDNA library was constructed from endoderm-like tissue, which was induced by treating disaggregated animal caps of Xenopus embryos at stage 8 (Nieuwkoop and Faber, 1967) with activin (Cao et al., 2001 ). The cDNA library was screened using large-scale whole mount in situ hybridization. We therefore could iden- Fig. 8 . A two-step model for primary neurogenesis. Early proneural genes define a broader proneural domain. Within this domain, the density of primary neurons is determined by the interaction between early proneural genes and lateral inhibition. At stage around 12.5, XETOR is activated also by proneural genes. Due to the antagonism between lateral inhibition and XETOR, it is possible that they can exert their functions in exclusive regions in the proneural domain. The region where XETOR expresses can be restricted as a result of repression effect of XETOR on late proneural genes. Thus lateral inhibition and XETOR comprise a dual inhibitory mechanism for primary neurogenesis. tify a partial cDNA of XETOR, with an incomplete coding region at 5 0 -end.
To isolate the 5 0 -end coding sequence, SMARTe RACE cDNA Amplification Kit (Clontech) was used, and the protocol of the kit was essentially followed. The final PCR product was purified and sequenced. A cDNA sequence with a complete coding region was obtained.
Constructs
To make an expression construct for microinjection, the open reading frame of XETOR was PCR amplified from cDNA reverse transcribed from stage 30 poly(A)
1 RNA, and cloned to EcoRI-XbaI sites of pCS21 to generate pCS21XETOR. A series of constructs of truncations were also made using PCR method. Inserts were all ligated to EcoRI-XbaI sites of pCS21. Truncation construct 1 (assigned as p13#trunc1) consists of amino acids from 1 to 496 with NHR4 deleted, truncation construct 2 (p13#trunc2) from aa1-425 with NHR3 and 4 deleted, construct 3 (p13#trunc3) from aa216-425 with NHR1, 3 and 4 deleted, construct 4 from (p13#trunc4) aa216-586 with NHR1 deleted, and truncation construct 5 (p13#trunc5) consists of aa364-586 with NHR1 and 2 deleted. All constructs were confirmed by sequencing.
Whole mount in situ hybridization
Protocols for whole mount in situ hybridization was essentially as previously described (Harland, 1991; Oschwald et al., 1991; Jowett, 2001 ). Probes were prepared as follows. XETOR and Xsox3 were cut with EcoRI and transcribed with T7 RNA polymerase, N-tubulin and Xngnr-1 were cut with BamHI and transcribed with T3, X-Delta-1 was cut with XhoI and transcribed with T7, Xaml1 and XNAP were cut with SalI and transcribed with T7, XMyT1 was cut with BamHI and transcribed with T7, Xath3 was cut with NotI and transcribed with T7, ESR1 was cut with EcoRI and transcribed with SP6, and Xash-3 was cut with NotI and transcribed with T3, and XNeuroD was cut with XbaI and transcribed with T7 RNA polymerase.
Microinjection
mRNAs used for injection were prepared as follows: NLSLacZ, pCS21XETOR, p13#trunc1, p13#trunc2, p13#trunc3, p13#trunc4, p13#trunc5, X-Delta-1 STU , XNotch-1ICD (Chitnis et al., 1995) , Xngnr-1 , XMyT1 (Bellefroid et al., 1996) , XNeuroD (Lee et al., 1995) , and Xash-3 (Zimmerman et al., 1993) were linearized with NotI; and Xath3 (Takebayashi et al., 1997; Perron et al., 1999) was linearized with AccI. All capped mRNAs were prepared with SP6 CapScribe kit (Roche). One nanogram mRNA of LacZ, 1-2 ng of XETOR and the five truncation constructs, 500 pg of X-Delta-1 STU , X-Notch-1ICD, XMyT1 or XNeuroD, 200 pg of Xngnr-1, or Xash-3 were injected in a total of 5 or 10 nl. A standard control morpholino oligo, ctrlMO (Gene Tools, LLC), was also used for microinjection. Morpholino oligos were dissolved in RNase-free water and injected with doses ranging from 7 to 30 ng in a volume of 10 nl. All injections were made into the equatorial region of one blastomere at two-cell stage, while the other one left as internal control. LacZ mRNA (50 pg) was always included as lineage tracer. Embryos were kept until neural plate stage (stages 14-16), then subjected to HEMFA (0.1 M HEPES, 2 mM EGTA, 1 mM MgSO 4 , 4% formaldehyde) fixing and b-gal staining as described (Coffman et al., 1990) .
Histological sections
After whole mount in situ hybridization, embryos were embedded in paraffin and sections were prepared as described (Penzel et al., 1997) .
